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INT:qODUGT I ON 
During the nast five y ears increas ing exp erimental evidence 
supplemented by limited clinical trials has shown that certain 
sulfonamide-like drugs and some new antibiotics have had an 
inhibiting effect upon tuberculosis, a disea s e that has p re-
viously remained refractory to chemotherapeutic attack with 
other a~ents . Successful chemotherapy in tuberculosis, beg in-
nin~ with Koch's disc overy of the tubercle bacillus and gaining 
further i mpetus from Ehrlich 's disc overy of a specific drug 
for the t reatment o f syphilis , has been t h e ob ject of extensive 
investi~ations but with uniformly disappointing r esults. In 
1932, Wel}G (l) reviewing t h e subject c oncluded t hat n o effec-
tive agent had been found that could cure or ameliorate the 
disease eith er in experimental animals such as the guinea pig 
or in man. Some of the agents that have been studied in t he 
past include various dye c ompounds, guaiacol, creosote, chaul-
moogrates , morrhuates, arsenicals, c opper,mercurials, gold and 
c ombined treatment with the salts o f the heavy metals . Corper 
(2) evaluating the data up to 1940 arrived at a similar conclu-
sion, namely that t h ere was "no specific c hemotherapeutic a g ent 
of n roven value in tuberculosis either in the sense of Ehrlich 
in whic h drup-s in lethal doses are able to kill all the specific 
disease nroducin&\ organisiD!i within the bod y at a single dose or 
in a etiolo ~ic or parasitotropic sense." Kolmer and Tuft (3) 
writin~ in 1941 C'Jncluded t hat tLe only agents t hat had been 
at all effective in the c hemot~erany of tuberculosis were the 
compounds of aold but these were considered, however , too toxic 
for general use . The rati onale and clinical results of gold 
therany may be found in a number of reviews . (1, 2, 3) 
This paper has been undertaken with the nurpose in mind 
of reviewinf the investi ~ative work and the development in 
research that followed the observation of Rich and Follis in 
2 . 
1938 (4) and 1939 (5) that sulfanilamide had a definite retarding 
effect upon the course of experimental tuberculosis in guinea 
pi~s and rabbits . An attempt is also made to evaluate the 
present status of chemotherapy as a method of t~eatment . 
Sulfonamide Theraoy in Tuberculosis 
The searct. for new drug s in the treatment of tuberculosis 
was resumed with furtber intensity following the report of Rich 
and Follis (4) that sulfonila_mide had a definite inhibitory 
effect upon exnerimentally indu ced tuberculosis in the guinea 
pi a . In 1939 (5) the y comfirmed their observations both on 
the guinea oi g and in the rabbit but in the latter toxic doses 
were ~ s cessar~ in order to duplicate t h e results seen in the 
~uine~ ~ig because of the rabbits' inability to attain and 
maintain a high concentration of the drug following a g iven 
dosage. The y concluded that retardation of the tuberculous 
orocess required t h e administration of an adequate do s a g e of 
the drug at re ~ular intervals in order to maintain a high blood 
concentration. 
Greey et al ( 6) confirmed t h e work of Follis and Rich with 
sulfanilamide but found various derivatives of prontasil inef-
fective and demonstrated that sulfanilamide exerted no influence 
uoon the course of tuberculosis in rabbits produced by the in-
travenous inoculation of bovine tubercle bacilli . Renal lesions 
were also unaffected. 
Kolmer, Raiziss, and Rule (7) reported that sulfanilamide 
and 6 derivatives administered intramuscul r rl y were without 
demonstrable effect in the treatment of exn erimental tuberculosis 
of g:uinea pigs. 
In 1940, Hinshaw and Feldman (8 ) tested the effectiveness 
of sulfapyridine and found that it exerted a definit e modifi -
cation and retardation of the exDected course and character 
of the disease in the ~uinea pi~s r eceiving t he drug . Tw enty 
animals inoculated with a virulent strain of tubercle received 
250 mgm . of sulfapyridine twice daily for three days prior to 
and ten days following infection. The dosage was reduced to 
125 mgm. twice dail y until 56 days post infection when the ex-
periment was terminated and the organs of the animals were com-
pared with a equal number of infect ed animals not receiving 
the drug . Comparative· necropsy studies showed that the extent 
of +he tubercul ous infe ct· on "'as no-'- ic eabJy less prominent in 
the treated animals esnecially in the spleen and axillary nodes 
where no gross lesions were demonstrable . Microscopically 
4 . 
there were small discrete enithelioid tubercles with no or mini-
mal caseation necrosis . as contrasted with those of the untre&ted 
animals . No nephrotoxic effects of the drug w~re noticed but 
in several instances grave and extensive changes occurred in 
the mucosa of the digestive t r act . 
Smith (9) comparing the activity of sulfapyridine and 
sulfonilamide showed that the former produced a better retarda-
tion of the disease in experimental animals and a better thera-
neutic blood level was maintained . Avera~e arbitrary units 
- ~ 
·of the disease ( on the Y;asis of 10 as maximum theorectical tuber-
culous involvement) was 9 . 6 for the cont rols , 6 . 5 for thos e 
treated with sulfamilamide and 4 . 2 f or those tre ated with sul-
fapyridine . 
In vitro tests ( 9) showed that sul fonilamide caused (: 
marked inhibition of tubercle bacillus culture growth at' dilu-
tions of 1:1000; sulfapyridine caused some inhibition of 1:5000 
and complete inhibition of 1 : 1000 . 
Although the sulfonamides have exerted a partial retarda-
tion upon the development of experimental tuberculosis, it h~s 
be en felt by the various authors (4, 5, 8) that their use in 
clinical tuberculosis has not been warranted since they would 
have to be used in toxic amounts and the animal experiments 
did not show sufficient retardation of the disease by the 
drurrs . The sulfonarnides have remained of theoretical and 
historical import ance in their relationship and similarity to 
the sulfones which were the next drugs to be investigated . 
5· 
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The Sulfone Compounds 
Followin~ the work with sulfanilamide in 1938, attempts 
were made to find comnounds relat ed to the drug that might 
have a stron:;rer theraneutic and less toxic effect · upon the 
experimental animals infected wi t h tuberculosis . M. I . Smith 
and his associates (10 , 23) of the ~ational Institute of Health 
conducted surveys of many sulfonamides, sulfones and phosphorus-
related compounds by a series of screening in vitr~ tests 
followed by animal exneriments . Rist, Bloch and H~non (11) 
had shown in 1940 that 4 , 4 ' diamino diphenyl sulfone (DPS) 
was more effective than sulfanilamide-;..ag ainst avian tubercu-
losis in rabbits . The studies of Smith and his associates 
showed the sulfone group of compounds to have greater in vitro 
activity than the other drugs studied . 
DPS which is the parent substance of some of the sulfone 
compounds was first investigated by Buttle , et al (12) in Eng -
land who compared its a ctivity with sulfanilamide in the treat-
ment of streptococcal infections in mice. They found that DPS 
was active in curing strept~coccal infections in mice in doses 
one - hundredth that of sulfanilamide but wa s twenty-five times 
more toxic . He found it not to be more toxic than sulfamila-
mide in normal rabbits and monkeys except that in the latter 
it 7as more active in n roducing metahemo ~lobinemia . ~he drug 
was also but slightly soluble in water . 
Search for a less toxic and more soluble sulfone was 
6. 
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deemed necessary . Bauer and Rosenthal {13) , in a similar study 
c1ropared the effects of sulfanilamide, DPS, its acetyl deriva-
tive , and the formaldahyd e sulfoxylate deriva tive (diasone) first 
prepared by them . They f ound DPS thirty times more effective 
than sulfanilamide against streptococcal infection in mice but 
it s high toxicity and insolubilit placed it a t a disadvantage . 
Diasone was observed to be five times more efficacious when 
administered sub cutaneously than sulfanilamide g iven orally . 
This was t h e first water soluble sulfone that s howed high thera-
neutic activit y against the streptococci . The sulfones were 
found to be less effective a~ainst experimental pneumococc a l 
infection than a~ainst streptococcal infection . 
Richard s on ( ll~), c omparing sulfapyridine, sul f'anilamide 
and DPS, produced in mice a hemolytic type of anemia associa-
ted with reticulocyto s is . He found that on the bas is of the 
minimal effective blood concentration which is necessary to 
p roduce a si gnificant effect in the red cells of mice, sulfa-
-
pyridine is one-half times as toxic as sulfanilamide whereas 
DPS is approximately twice as toxi c as sulfanilamide. 
The DPS derivative t hat was first used in an elaborate 
s t udy in the treatment of exnerimental tuberculos is wa s the 
sodium p, p 1 di amino d±phen:rl sulfone 4n, n 1 didextro se sulfon ate 
{n romin) employed by Hinshaw and Feldman of the Mayo Clinic 
{15-18) . This c ompound had be -n test ed previously by Toomey 
and Roach (19 a) in clinic a l s t r eptococcal infe c t ions. The y 
gave apnroximately 1500 int ravenous inj e ctions t o over 150 
patients . In a dosa~e of 5 gms . thrice daily, they felt thst 
the patients seemed to tolerate the drug better than either 
sulfanilamide or sulfapyridine and in the dosage indicated it 
did not cause the destruction of either hemoglobin cont ent or 
the erythrocytes . They found it to have a definite beneficial 
effect upon the streptococcal infect ions especially of the 
upper respiratory tract and erysipelas . They felt that its 
disadvantage was the necessity for intravenous administration 
but its advantage lay in the fact that it did not Produce 
crystals or concretions in the kidney. Toomey and Takacs 
(19 b) had shown that doses up to 35 to 40 gms. intravenously 
did no~ Produce urinary concretions in the monkey. Toomey 
and Roa:Jh were of the opinion that Promin was of considerable 
value in the streptococcal infections that they had treated . 
Though these observations may seem somewhat far afield 
from the subject at hand, nevertheles s they serve to demonstrate 
the relationship which the sulfones bear to the sulfonamides . 
and their ability to combat certain infections that are suscep-
tible to sulfonamide therapy . It also strengthens the supposi-
tion that the sulfone s have a mode of action similar to that 
of sulfonamides. The apparent innocuousness of promin ad-
ministered intravenously for short periods of time serves as 
an inieresting contrast to the marked toxicity which it later 
d~m6nstrated when given orally in the treatment of tuberculosis . 
8 . 
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Prom in 
General Remarks 
Feldman and Hinshaw of the Mayo Clinic, working on the 
problem of chemotherapy in tuberculosis, were engaged in the 
search for a sulfonamide-like compount that exerted a benefi-
cial effect without being too toxic . Their work with sulfa-
pyridine (8) has already been de s cribed. They next tried a 
similar experiment with sulfathiazole but could demonstrate 
no inhibition of the tuberculous proce s s with this drug (22). 
Following this, in 1940 they began to study promin, a product 
of the research laboratory of Parke, Davis and Company. 
_.,. Q l'l H ~ "' ( C H o 1'\ )tt C H. o ~I 
, ~ \ 
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Promin is the sodium salt of p, p ' diamino diphenyl sulfone 
n, n' didextrose sulfonate. Its parent substance is DPS whose 
efficacy in streptococcal infections has already been described. 
Promin varies in its solid form from white to light yellow and 
is slightly hygroscopic. It is highl y soluble in water; 40 
per cent s olutions are stable indefinitely and may be sterilized 
by heat . The drug is slightly bitter but has been administered 
with the meals of both experimental animals and man without 
impairing the apuetite or producing any other recognizable 
gast rointestinal disturbances in low concent,rations. In the 
experimental animals it was tolerated in a 1 per cent concen-
tration of the feed (300 to 400 mgm . dail y dose) but a 2 per 
10 . 
cent concentration gave deleterious effects and anorexia . On 
this dose effective blood levels have been maintained that 
varied from 2 . 3 to 4 . 3 mgm . per 100 ml. blood serum . Parenteral 
administration of the drug has not been considered feasible . 
The concentrati0n in the urine, blood, and other body fluids of 
all the sulf :~me drugs that have been studied has been deter-
mined by the method of Bretton and Marshall (20). 
Animal Experiments 
In a serie s of well controlled experiments (15, 16, 18, 
21, 22) Hinshaw and Feldman show ed that promin exerted a deter-
rent effect up~~ ~1e development 'of experimental tuberculosis 
in guinea pigs, , , that it suporessed the appearance of the 
disease as long as the dru p: was administered, that it arres ted 
the progress of the disease when the drug was started as much 
as six weeks following infecti on with virulent tubercle bacilli, 
and that under the influence of the the drug, typical progres-
sive le s ions of the disease re ~ressed or resolved entirely . 
In the first experiment (18) one group of 30 animals re-
ceived 300 to 400 mgm . of the drug in a 1 per cent concentration 
in the feed for 2 days prior to the infection with strain 
H 37 RV tubercle bacilli and daily thereafter . When all the 
controls had died 82 days post infection, 24 of the treated 
animals were still living . At thattime the drug was removed 
from the diet of one-half of t h e animals most of whom developed 
a typical oicture of tuberculosis and died soon after. Although 
the lesions of nrogressive tuberculosis were present in the 
11 . 
organs of predilection of all the control group, the degree ·of 
involvement in the animals that had received promin was noticably 
less . Fewer sites were affected and the lesions were less 
numerous and smaller than in guinea Pigs that were untreated . 
Furthermore in the spleen, lungs, liver of approximately 50 
per cent of the treated animals no cellular reactions that 
could be considered tuberculous were observed either grossly 
or microscopically . 
A second experiment (18) was performed to confirm there-
sults of the first and to determine if promin would ' have an ef-
fect on tuberculosis infections introduced at the same time 
or at varying periods before tre c>.tment with promin wa~: begun . 
A group of animals was infected and treatment was begun at vary-
ing intervals as follows (a) day of infection, (b) 3 days after, 
(c) 1 week after , (d) 2 weeks after , (e) 4 weeks after, and (f) 
6 weeks after. A group was treated as in the previous experi-
ment . At the exniration of six mont hs all the untreated animals 
had died but 84 per cent of the treated animals were alive in-
cluding those whose treatment beaan six weeks post infection. 
Among the animals that had received Promin demonstrable lesions 
of tuberculosis in the liver, spleen, and lungs were absent 
in 57 ner cent and small scattered lesions were present in the 
rest of the animals . These two experiments demonstrated that 
promin had a definite deterrent effect on experimental tubercu-
losis infection. 
A third experiment (21) was Performed whose purpose was 
to confirm the first two experiments, to determine whether 
tuberculous le s ions were actually present at the beginning of 
treatment and whether these lesions r egressed or were resolved 
as a result of promin administration . A group of animals were 
inoculated with virulent tubercle bacilli and 42 days later 
when the animals were found to be sensitized to tuberculin 
subcutaneously administered, treatment was started on some of 
the guinea pip:s . One·week later biopsies were taken from · the 
treated and control groups. As a consequence of observation 
at biopsy it was determined definitely that tuberculosis was 
present in the livers of both the treated and untreated animals. 
at the time wh en treatment was begun . The experiment continued 
until the last of the control group had died 224 days after 
infection . At that time only 19 per cent of the treated ani-
mals had died . At necropsy, results of the study showed that 
the hepatic lesion present at laparotomy had regressed or dis-
anpeared entirely . The authors found that hepatic cul t ure s of 
bacilli were ne~ative except for one-eighth of the animals 
and concluded from this observation that the causative organism 
was eliminated from the body during the process of treatment. 
This observation was, however, disproved in later work by other 
investi gators (24) and the authors (25) themselves . The results 
of this study confirmed the previous reports that promin was 
capable of exerting a definite therapeutic influence on pre-
viously established experimental ' tuberculosis. The procedure 
followed provided morphological evidence that in most cases 
12 . 
tuberculous lesions present when treatment be ~an resolved or 
became regressive under the influence of the therapeutic agent . 
These observations and results led other inve stigat or s 
and the authors (24-28 ) to perform more exneriments which in 
general have confirmed the efficacy of promin the the treatment 
of exuerimental tuberculosis. Armstrong , et al . (29) were un-
able to r eproduce effects comnarable with those obtained by 
Hinshaw and Feldman but attributed their failure t o faulty ex-
perimental methods and conditions . 
13. 
Medlar and Sasano (24) found that after promin therapy was 
stopped following the death of all the untreated controls, thetreated 
animals died of tuberculosis and culture s of tubercle bacilli 
were obtained from the spleens of 77 per cent of the animals 
that had shown no macroscopic evidence of visceral tuberculosis . 
Hinshaw and Feldman (25) likewise demonstrated a continuance 
of the tuberculous nrocess followin~ cessati on of treatment with 
promin and that nrolon~ed therany had no effect on t he subse-
quent reinfe ction of animals with virulent tubercle bacilli. 
This would seem to indicate that promin exerts a suppressive 
rather than a curative effect on the disease in guinea pigs and 
the a~thors felt that apnarently favorable resul ts with the 
.drug had t o be interpreted with due conser vatism.regarding its 
possible use in the treatment o f human tuberculosis. Medla)r 
and Sasano felt that these observations did not preclude the 
use of nromin in clinical trials on tuberculous patients since ~C 
t he factors of natural re s istance and immunity which play a 
part in the amelioration of the disease in man are entirely 
lacking in the guinea pig which possesses practically no natural 
immunity to the dis ease and in whom the disease is uniformly 
progressive and fatal . The inve stigators in this field have 
c ont inuously stressed the avoidance of overoptimism and have 
advised a cautious c onservative attitude when interpreting 
experimental "cures" with relation to possible efficacy · in 
human infecti on . Promin as proven by these controlled experi-
ments did not cure guinea pig tuberculosis and eradicate the 
infection from the animal body. The re search undertaken in 
the chemotherapy of tuberculosis has been an attempt to find a 
substance that will provide a "cure" as defined by criteria 
that have been set down in other experimental and clinical 
studies . (See PP• 54-59) 
Other experiments deviatin~ from the original work by 
utilizin~ various m0difications of method have demonstrated 
c0muarable suppressive and retarding effects in experimental 
tuberculosis (26, 27, 28). Hinshaw and Feldman (26) demonstra-
ted a suppressive effect when treatment with ·promin was started 
6 weeks post infection and given every alternate week. Steenken, 
Heise, and 'Nolinsky ( 27) showed that vaccination of gu inea pigs 
with an attenuated strain of living tubercle bacilli combined 
with promin therapy induced a greater inhibition of the progress 
of the disease than promin theraPy in unvaccinated animals. 
Barach, Molomut, and Soroka (28), comparing the use )f promin 
administered in the form 0f spray with promin taken ,orally 
14. 
f~und that desuite a lower blood concentrati on of promin in 
animals who had inhaled the nebulized spray, the degree of pul-
m~nary as well as generalized tuberculosis was less than in 
the orally fed group . Clinical application of this method of 
administration (43) has proved unsuccessful, however , 
The favorable suppressive effects obtained by Hinshaw , 
Feldman, and others in their animal exneriments m~de them 
feel that a trial of promin in suecially selected patients was 
warranted; however, sneculation concerning its efficacy had 
15. 
to be temp ered and somewhat reserved. Although both are pro-
duced by the same etiologic agent, human tuberculosis is a 
protean disease and is a different disease from that in the 
guinea pig . , Most authors working in the field have been consis-
tently cautious in their interpretation of experimental results 
with reference to the possible effectiveness of chemotherapeu-
tic agents in human tuberculosis . 
In Vi tro Exneriments 
Promin and DPS , its parent substance , are able to exert 
a tuberculos tatic effect in vitro (30-34) . 
Steinbach and Duca (30 ) found that promin when added t o 
Sauton ,ts medium in concentration of 40 mgm . per 100 ml. inhi -
bited t he growth of two virulent strains of tubercle bacilli 
for 30 days 1 after which the organism began to g r ow . No change 
in mornhology , staining reactions or virulence occurred in the 
organisms that remained under these c onditions f or 30 days and 
when inoculated .int o guinea Di gs nroduced an invasive tuber-
culosis . 
Emmart and Smith , however, using an A 27 strain of tubercle 
bacilli grown on a cult ure medi um of beef bouillon , 5 per cent 
glycerine with 10 mgm. per 100 ml. of promin showed that the 
-
virulence of t he s e or gani sms was attenuated in v arying degrees 
for a period of from 24 hours to 104 days , 31) . They found 
that reduction in virulence in t he promin-treated strain per-
sisted after the organisms were returned t o the c ontrol media . 
and that the change in virulence could be demonstrated by 1m-
plantation on the chorioallont oic membrane of the chick embryo 
a R well as b y inoculati on into guinea pigs . They felt, however, 
that t he a +tenuating effect of nromin wa s slight . 
Steenken and Heise (32) comparing the inhibitory effect of 
promin and DPS on the growth of tubercle bacilli concluded that 
a far greater concentration o f promin is required f or in vitro 
inhibition than is necess ary f or ret ardation of the diseas e 
16 . 
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process in the guinea pigs as reported by Hinshaw and Feldman . 
They reported that DPS produces a much greater inhibition upon 
the growth of the organism when added to the media on a calcu-
lated basis of the available amount of the parent substance 
DPS present in promin which is about one-third the molecular 
wei [~ht of promin. They felt on the basis of this finding that 
the parent substance, weight for weight, is more effective 
against the tuberculous process in guinea pigs . They found 
that the effects of 'lromin and DPS were neutralized when p-
amino benzoic acid was a dded to the medium • 
. Floyd and Middlebro ok (33) tested the effects of pH, tem-
~perature, and salicylates on the bacteriostasis of tubercle 
bacilli by sulfonamides and DPS . They found that the sulfona-
mides exerted their bacteriostasis in a nH 5 · 5 to 8 . 5 . The 
bacteriostatic renr-:e of sulfathiazole increased with a higher 
' pH whereas sulfadiazine exerted its maximum effect at pH 5 · 5· 
The activity of DPS also v aries but its ,maximum effect is at 
pH 3 . 5 . Slight increases in temperature had no influence on 
the a ctivity of the sulfonamides and DPS . Salicylic acid and 
DPS seemed to be additive in their b acteriostatic effect on the 
strain of bacteria used in this experiment . 
On the basis of this and other studies, Middlebrook (34) 
has nostulated a possible mod e of activity of the sulfonamides 
and sulfones against the tubercle bacilli . He beli eves that 
the c hange in activit~ ~f DPS at a higher pH cannot be related 
to acid dissociation but may be related to basic d i ssociation 
17 . 
of the para-amino group in such a manner that more of the un-
dissociated coumpound exists at higher pH values. This sug- . 
gests the theory that this form of the compound has more bac-
teriostatic capacity for permeating the peripheral structures 
of the tubercle bacillus in order to reach the susceptible en-
zyme system. The author feels that whether this variation in 
I 
the bacteriostatic activity with pH depends on changes in· 
the drugs themselves , changes in the permeability of the peri-
pheral structures in the bacterial cell or changes of the en-
syme surface where the drup.:s presumably compete with ~-amino 
benzoic acid is still unknown . Middlebrook (34) has proposed 
18. 
a ba sic formula common to all drugs whose activity is inhibited 
by p-amino benzoic acid and which show tuberculostatic activity. 
The re sults of these in vitro exrieriments would tend to 
make apparent certain conclusions regarding the possible mode 
of action of the sulfone group of compounds. in tuberculosis . 
1) They are bacteriostatic, not bacteriocidal . 
2) Their activity is inhibited by - p-amino benzoic acid . 
In these respects they re s emble the sulfonamides but 
their activity at a higher pH might render them 
canable of a more s~ecific deterrent effect on the 
tubercle bacillus . 
3) Promin is definitely less active in vitro than in vivo . 
I t has been felt as a result of exneriments (39) that 
promin administered orally is hydrolyzed in the intes-
tine to release the parent substance DPS which shows 
greater toxicity but is more effective against experimental 
tuberculosis . This might apparently account for the 
fewer toxic manifestations of promin when administered 
parenterally than when given orally . 
19 . 
Many workers in this field have felt that in vi t ro tests 
are of little velue as an index for the tubercula-therapeutic 
activity of drugs under investigation. In vitro c~nditions do 
not approximate those found in the animal and human body . Tests, 
therefore , may give results that are not comparable to the ac-
tivity of the drug in vivo . Metabolic and other environmental 
conditions may render active a drug which does not demonstrate 
any marked degree of effectiveness under the artificiality of 
the in vitro medium . Therefore, the criterion which most men 
feel warrants the cl i nical tr i al of a new drug is chemothera-
peutic effectiveness combined with low toxicity in animal expe-
riments . 
Clinical Use of Promin 
Encouraged by the ~rornising observations in experimental 
tuberculosis , prompt clinical application of sulfone therapy 
was started on a group of volunteer patients at ~ ineral Springs 
Sanatorium in March , 1941 , which has formed the basis for two 
progress reports by Hinshaw, Pfuetze , and Feldman (35, 36) . 
Prornin was administered orally to a total of 106 patients but 
only 36 received sufficiently large amounts of the drugs to 
have been included in the study . The first report (35) dealt 
with the course of the patients up to January , 1943 . 1 . 2 to 
1 . 6 gm . in averape doses of 0 .8 grn . of nrornin was administered 
daily and therapy was interu~ted for a week or two when sub-
jective or objective evidence of toxicity occurred; i . e ., 
mainly anemia . A decrease in the sedimentation rate in all 
20. 
patients anneared sor:>n after treatment was begun but the authors 
considered this finding too non-specific to be used as a criterion 
for imprr:>vement. The criteria utilized were clear·ing of the 
chest plates and snuturn reversal. They found that imnrovement 
appeared to be most rapid and consistent in ~ati ents who had 
recent lesions of the exudative type without extensive destruc-
tion or prominent fibrosis but since lesions of this type tend 
to improve spontaneously it could not be determined definitely 
whether or not the drug contributed to the rapid improvement 
in this series of patients . 
Apparent reversal of snutum was observed in 39 per cent 
(14 cases) of the adequately treated group after 4 to 12 months 
of chemotherapy. Apnarent closure of cavities was observed 
in 25 per cent (10 cases) of this group. The sedimentation rate 
improved si _nificantly in 70 ner cent of the patients. Four 
natients died despite adequate therany and in one case extension 
of the disease occurred despite treatment. Six patients with 
tuberculous menin itis who had been treated for relatively brief 
periods all succumbed. With these incomplete observations the 
authors concluded that further studies had to be made before 
definite C)nclusions could be reached . 
The second renort of progress (36) describUg the clinical 
cr:>urse un to December, 1943, shovred thet the originally descri-
bed clinical trends had been consistent and nrogressive but 
the number of treated cases was not sufficiently large and the 
observations not adequately controlled to permit unqualified 
21 . 
conclusions regard ng the value of promin as a therapeutic agent 
in the treatment of tuberculos i s . 
The patients were classified into four groups : 
Grouo I . " No improvement " reported of 8 patients 
in the first report . One patient with a bronchostenotic le s ion 
improved sufficiently t o ·be dismissed . Two received c ollapse 
therapy and were progressing well , 5 patients remained stationery, 
and one died of pulmonary hemorrhage . 
Group II. "Slight improvement" reported of 8 patients . 
Six were improved since the fir st report, two with the aid of 
·thoracoplasty . Tw o cases showed no improvement. These were 
all cas e s of poor prognosis and ex ensive tissue destruction . 
Group III . 11Moderat e improvement " reported of 12 
patients . There was a Eeneral good trend with clearing of the 
chest films in most c ase s . There wa s sputum reversal in seven . 
Group IV . "Marked improv ement" was reported in 8 
patients with suutum reversal i n seven . One patient still had 
a large c avity ~ There was improvement and resolution of lesions 
as determined by chest plates . I n all cases t he trend of the 
disea se had been serious . Five had been classified as "far 
advan ced " and 3 cases as "moderately advanced . " The s e patieht s 
had been g iven large doses o f pro-min since 1942 . 
Chemotherapy was discontinued in 20 cases for periods of 
10 to 25 months . Only 3 patients suffered reactivation of the 
proces s (2 of the s e had left the sanatorium a gainst med ical 
advice) and two patients who received t h e drug a gain b egan to 
improve . These result s in human tuberculosis a r e in c ontrast 
with the observations of Medlar and Sasano (24) in the discon-
tinuance of treatment in exuerimental tuberculosis and may be 
an example of the possible role that promin had in suppressing 
the infection, allowing the natural immunity of the patient 
to prevent reactivation of the disease . 
The authors agE.in stressed the apparent efficacy of chemo-
therapy in patients with recent exudative lesions rather than 
in patients with extensive lesions which involve caseation, 
t 
necrosis, cavi#tion and fibrosis . Precaution in preventing 
the toxic effects of promin we r e re- emphasized . They felt that 
t he t'Jxic manifestations of nromin and related drugs are to be 
constantly reckoned with but are measurable , reversible, con-
trollable and do not appear to have an edve~se Rffect upon the 
clinical course of the disease . ( See pp.29-3lj They concluded 
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as a result of these studie s t hat promin was not the ideal thera-
peutic agent and was not the crucial factor in recovery but com-
bined with sanatorium rest and surgical. collapse t herapy served 
as an adjunct to treatment . 
Zucker, Pinner , and riyman ( 37) reported the use of promin 
in a series of 12 cases where t he drug was administered parenteral-
ly by the i ntravenous route in a 4 week course of treatment . 
The natients included in this study had minimal, moderate or 
far advanced nulmonary tuberculosis , miliary tuberculosis, 
tuberculous meninaitis, tuberculous tracheitis and bronchitis . 
They gave the drug in daily dc:ses of 15 to 25 gms . ( 300 t o 400 
gms . per kg . body weight) in a 1 to 2 percent solution by 
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intravenous drip for 10 hours . The initial dose of 5 gms . was 
given within 8 to 10 minutes . Despite the l a rge dosages the 
blood levels of the drug were rather low probabl y because of 
rapid excretion by the kidneys . No toxic reactions were noted 
when 15 gms . or less were given and onl y sli ght reactions were 
noted in some cases with 25 gms .; namely, noderate hemolytic 
anemia in one case , slight anorexia, fever up to 1010 F., cynosis , 
weakness or headache . The authors , discovered no beneficial 
effects from this mode of administration except in one case of 
unexpected healing of a tracheo-bronchial ulceration which could 
not be defini tely ascribed to the drug . The ineffectiveness 
of the drug in this series is probably due to the route chosen 
for administration since promin i s metabolized differently when 
~iven orally than intravenously . ( See p .25) The course of 
treatment was also short in compari son to t :.ose in other studies . 
Heaf , et al ·(38) in England and Dancey , et al (39)_ condue-
ting clinical trials with nromin reported results similar to 
those 0f Hinshaw, Pfuetze , and Feldman and came to the same 
conclusions regarding the efficacy of the drug in the treatment 
of tuberculosis . Heaf and his coworkers (38) treated 14 patients 
with pulmonary tuberculosis; 4 with pulmonary tuberculosis and 
tuberculous laryngitis , and one with genito-urinary tuberculo-
sis . They prevented the occurrence of anemia by administering 
iron . I n several cases where they administered promin intra-
venously they found no anemia . , It was their opinion that pro-
mine should not be given by mouth for far advanced cases of 
pulmonary tuberculosis with toxemia and low resistance because 
of the nroduction of anemia . In 2 cases they found rather rapid 
healing of laryngeal lesions when promin was applied locally 
in an oily medium . Some "improvement" in the case of genito-
urinary tuberculosis was noted and they felt that this required 
further investip-a.tion . 
In June, 1944 , Dancey 1 Schmidt, and Wilkie (39 ) reported 
the use of promin at the Wisconsin State Sanatorium in 27 
patients with tuberculosis of whom 16 were c onsidered adequately 
treated . The standard initial dose was 0 . 4 gm . increasing 0.4 
gm . every 10 days. until a maintenance dose of 1 . 2 gm . per day 
was reached. In "adequately" treated cases the doses ranged 
from 0.66- 2 . 0 gm . ( Ave . 1 . 07 gm .) for 1 to 12 months (Ave . 
5 1/2 months) . Toxic rea~tions occasionally necessitated 5 to 
7 day rest neriods . Cansufes containing 0 . 4 gm . were usually 
given after meals . Gastrointe stinal reactions were avoided by 
giving fruit juices or 1 to 2 drams of gelatin , by varying the 
time between meal and drug administration or by subdividing 
the dose . Some of the pat ients received promin intravenously 
or intramuscularly 1 to 3 times a day to supplement oral treat-
rnent or in those cases where the patients were too sick to 
tole rage the drug orally . Intravenous doses were usually 5 
gm . in a 40 per cent aqueous solution . This caused slight pain 
and. frequentl :r tl1rombosis which co t:ld be avoided by using a 
5 per cent glucose solution . Intramuscular injections of 5 ml . 
of a 40 ner cent promin solution caused nain but maintained a 
satisfactory blood c oncentration during the ni ght in lieu of 
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oral doses. The average blood levels after 1.2 gm . orally 
were 4 to 6 m~m . Per 100 ml . blood serum and urine levels were 
60 to 140 mgm. per 100 ml . urine . 
In attempting t~ discover Possible changes that promin 
might undergo in the ~astrJintestinal tre~t , pancreas susnen-
sions were added to soluti~ns of the drug and a greater color 
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concentra '· ion was obtained afterward using the method of Bratton 
and Marshall. It was felt that romin was chan:'·ed to a more 
toxic compound, possibly DPS which might account for the toxi-
city of the drup: . This seems to correlate well with the ob-
serva tions that DPS has a greater tuberculostati c effect than 
promin (32) and that promin shows limited t oxicity when adminis-
tered intravenously . 
qeactions noted in thisreries (and in other patients re-
cei vinl2' the dru g but not included in the study) were as follows: 
Anemia 32 
Cyanosis 30 
Gastrointestinal 17 
Headache 11 
Albuminuria 8 
Jaundice (mild) 6 
Psych'c symptoms 5 
Weakness and fati-
pue 6 
cases 
II 
II 
II 
II 
II 
II 
II 
Sluggishness and malaise 5 
Skin rash 4 
Aching of limbs 2 
Transient tachycardia 2 
~ild fever l 
Leukopenia (4,950) l 
Paresis and s pasticity 
of lower limbs l 
ca s es 
II 
II 
II 
II 
II 
II 
Of the 16 uatients condiered adeauately treated, 5 showed 
"marked clinical improvement" , 4 "moderate improvement", 6 "slight 
improvement", and l "no imProvement"; however, x-ray findings 
were less satisfactory and did not show resolution of lesions 
consi s tent with the clinical imurovement. Films showed progres-
sion of the disease in two patients considered adequately treated . 
An acute tuberculous pneumonia in one patient was treated early 
and terminated ranioly. Several patients were poor surgical 
risks before Promin therany but later underwent thoracoplasty 
success fully. 
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In the li~ht of these conflicting results it is somewhat 
difficult t0 evalu~te the efficacy of Pr0min treatment in these 
-oatients. Sputum results were n0t re-::)')rted and the chest films 
were contradictory so that definite conclusi')ns cannot be reached. 
Subjective feelings and symptoms are not reliable as a scienti-
fic yardstick for the improvement of pulmon~ry tuberculosis . , 
It was the authors' opinion that "improvement" was greater than 
could ordinarily be expected with the usual methods of treatment 
and that recent exudative lesions were more amenable to treat-
ment than chronic lesions . They felt that promin was not too 
potent in human tuberculosis but that it could possibly be used 
as an adjunct to other methods of treatment . The results in 
this series should perhaps have been subject to greater critical 
analysis on the ba s is of objective findings before a report of 
improvement was justified, but, nevertheless, promin may have 
been of some slight value in the treatment of the disease . 
Promin has proved completely unsuccessful in treating 
tuberculous meningitis . Morrow, Epstein, and Toomey (40) re-
ported the treetment of 11 patients to whom the drug was adminis-
tered intravenously 4 to 14 days following onset of symptoms . 
No beneficial results occurred and the disease terminated fatal-
ly . 
Local apnlication of promin to tuberculous lesions has 
shown samewhat mor; encoura~in~ results in a few instances 
(41, 42 , 43) . Crawford (41) reported 4 cases of tuberculous 
empyema in which 40 ml . of a 20 ner cent promin solution in 
glucose were injected twice at fortni ghtly intervals into the 
Pleural cavity . In 3 case ~ tubercle bacilli c ould no longer 
be found in the effusion, but one case was unimproved . The 
rate of farmation of fluid decreased considerably after aspira-
tion, followed by injection of the ryromin solution . The author 
felt that his treatment would not obviate the necessity for 
thoracoplasty but the presence of the glucose in the solution 
might encoura~e pleural symPhysis and improve the chance for 
success of the operation . 
He reports one ca se of tuberculous peritonitis with recur-
rent ascites treated by the intraperitoneal injecti on of 60 ml . 
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of 5 per cent solution af promin in gluc ose following paracentesis . 
Previously 5 liters of fluid had been aspirated at laparotomy 
and 5 pints at several short intervals thereaft f r. Nine weeks 
after instillation of the nromin soluti on there had been no 
recurrence of ascites and improvement of the general condition 
and sedimentation rate was sLriking . 
These results, t nough not conclusive, were thought to war-
rent further trial in many ce ses of tube r culous effusion . 
Tyf ler and Lapp (42) u sed local ly a 5 per cent promin jelly 
in a trasocanth base in 5 cases of closed tuberculous abscesses . 
and 5 onen tuberculous sinuses . In the 5 closed cases the c old 
abscesses were resolved soon after treatment, much sooner than 
with the conservative measures previously used . The lesions 
were not comnletely sterilized , however . The 5 onen sinuses , 
some having a fairly lon~ history of drainage, responded well 
to treatment . One sinus was completely healed, and the others 
closed down to small openings with only slight drainage . In 
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2 cases there was a rise in temperature on the day after treat-
ment wrs started but no other toxic reactions were noted . The 
auth0rs believed that while the results were somewhat irregular, 
the clinical opinion was that improvement in all cases was greater 
than would have b : en expected by orthodox methods applicable . 
I n 1 case especially the results were spectacul a r in that three 
d i f ferent abscesses healed comnletely within two weeks of treat-
ment leeving only small fibrous residues . 
Edlin, et al . (43) attempted the treatment of 24 patients 
with nulmonary tuberculosis by the inhalation method but met 
with no success except possibly in a few cases . The types of 
lesions treated were : 
1 . Fresh or exudative . 
2. Mixed infiltrative 0r exudative productive . 
3· Tuberculous cavities, recent or old . 
4 . Bronchiectasis associated with tuberculosis . 
5. Tuberculous endobronchial ulcers . 
This treatment anpeered to be of little value in parenchy-
mal tuberculous lesions possibly because of the difficulties in 
administration and lack of adequ&te blood concent l ation . It 
seemed to be of some benefit in endobronchial ulceration and 
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demonstrated its best results in one cas e of bronchiectasis . 
In 23 cases there was cyanosis which apPeared in the early 
part of the first week and oc casionally during the second week 
of treatment . It was of slight degree and therapy was not in-
terrupted . In 4 cases, ~a stric symptoms or headache, or a 
combination of the two anpeared after 1 to 2 months of treat-
ment . In one-half the cases a mild anemia appeared at the end 
of the third or fourth week of treatment. These were reversible 
without any alteration of treatment by givin~ liver and iron . 
Toxicity 
One of the chief disadvantages in the administration of 
nromin and the sulfone group in general both experimentally and 
Clinically is its tendenc;r to cause a marked hemolytic anemia . 
This was first noticed by Hinshaw and Feldman (17 , 44) when they 
started clinical trials with the drug in 1941 . They found that 
intravenous doses a s high as 16 mg . were well t olerated . On 
the other hand oral administration of 1.6 to 3 . 2 . 3m . of promin 
for S to 10 days uniformly cau s ed a hemolytic anemia in most 
of the patients . Patients tolerated the drug less readily than 
guinea pi~s on the basis of bod.r v1e ight. Only one-half to 
one- third of the Patients tolera.t ed the drup; well enough to 
give blood concentrat ions co"'TIPBr£' le to th')s·e in tr_;_e rruinea pig . 
The anemia was associated with signs of increased blood regene-
ration a s characterized in dry smears by anisocytosis poly- - .-
chromatophilia , and reticulocytosis . vhen administration of 
the drug was discontinued, the hemoglobin and erythrocyte 
concentrations returned to pretreatment levels in a few days 
often with remarable . aoidity . In no cases was apla oia or ex-
haustion of the hemopoietic system found . By giving smaller 
doses, and with adeauate supervision and study of the blood, 
the authors could control the anemia and treatment was continued 
with these smaller dos es . Other authors (38, 43) have control-
led the anemia by usinc ir)n or liver preparations . 
Higgins (45, 46) showed thst a single injection of 4oo 
mgm . of uromin in guinea oigs nro~ uced cyanosis, anemia, and 
marked tendency toward crenation of the red cells within 18 to 
24 hours . In addition the drug caused in some animals paralysis 
of the hind limbs and a general flaccid condition in all the 
muscles . 
Attempts to modify the toxicity of promin in exper imental 
animals by dietary measures (47- 49 ) showed that brewer's yeast 
(47) neither improved the blood dys c rasia nor affected the 
therapeutic results of the drug . An increased consumption of 
certain comnonents of the vitamin B complex (48) and whole liver 
associated with a hi ah orotein diet (48) were found to decrease 
the toxicity of promin in young rats . 
The toxic effects of oromin on the blood are usuall y pre-
dictable , controllable, and revers i ble when adequate precautions 
and study are carried out . In view of its harmfulness, the drug 
has been studied clinically only under c arefully supervised 
con~itions where facilities were available for thorough study 
of its toxic potentialities . Other toxic effects have been 
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enumerated in the discussion above . 
The results of clinical trials have been slightly encouraging 
but inconclusive, so that nromin cannot be considered an ideal 
chemotheraneutic agent in the treatment of tuberculosis . 
32. 
Diasone 
In the search for a more effective and less toxic compound, 
attention was next turned t~ the disodium formaldehyde sulfoxylate 
derivativ~ 6f DPS called "diasone" . Its c h emical and physical 
pronerties are similar to those ~f promin . 
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This c omnound wa s synthesized almost simultaneously by 
"Ra.iz iss and Bauer in 1938 . It was first 's tudied in c omryarison 
to sulf0namides in the treatment of strentococcal infections of 
mice by Bauer and Rosenthal (13) and in compa r ison to other sul-
fone s in the treatment of experimental tuberculosis by Smith, 
Emmart, and Stohlman (50) who did not consider its activity as 
being very striking . Callornon ( 51) showed, however, that it had 
a marked inhibitory effect on experimental tuberculosis in guinea 
pigs and that it showed the least toxicity Or incidence of mor-
tality than the other sulfone ? and sulfonamides studied in his 
series . This pr)rnnted Feldman and Hinshaw (52) to te e t the com-
pound experimentally by a· etr.)d similar to that emplpyed with 
oromin . They de~~nstratedthat 1iasone produced comparable t hera-
peutic iffects combined with low toxicity . 
The results of clinical trials wit h diasone have provoked 
c onflictinq opini0ns re~arding its efficacy. By some, its 
therapeutic properties have been given lukewarm praise, and by 
~thers they have been severely condemned . 
On the basis of the experimental work by Hinshaw and Feld-
man, Petter and Prenzlau (53) started the administration of the 
drug to 142 uatients at the Lake County Tuberculosis Sanatorium , 
Waukegan, Illinois, and later renorted the results 0f treatment 
on 44 cases (54 , 55) . Their work has been reviewed by other 
authors (56- 59) . 
In a nreliminary publication they reported general improve-
ment on the basis of chest plates and sputum conversion in 73 . 2 
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per cent of the 142 patients and followed this soon after with a 
more detailed account (54) on the results of therapy of 44 of these 
natien~s receiving the treatment . The patients were all volunteers 
who had been chosen because they had shown little ra sponse to 
bed rest and were se c(' te4 on the basis of having infiltrative 
lesions without cavi tation theori tically similar to lesions in 
the tuberculous guinea pig . Definite favorable changes in sym-
ptoms and objective findings were noted after 60 days of treat-
ment . They felt that the drua was being given a relatively severe 
test practically alone by not bein~ given in conjunction with 
other modes of therany, 1 . e . , bed rest , in some ambulatory 
patients, and without collapse therapy in a certain portion of 
the cases . 
Prior to the administration of diasone each patient was 
examined carefully and a nre-treetment record was made of the 
physical findin~s , x- ray, wei~ht , temperature, and nulse . Labo-
ratory data was recorded of snutum analysis, urinalysis and blood 
study (he~oglobin , red count, total and differential white count, 
and sedimentation rate) . 
During the administration of the drug daily records were 
made of objective findings and subjective symptoms. At weekly 
intervals hemoglobin content, red count,concentration of diasone 
in the blo0d was determined. Every 4 weeks, total and differen-
tial white counts, sputum, chest plates, chemical and microsco-
Pical studies 0f urine were carried Dut . 
Diasone was administered in dosages of 1.0 gm. per day 
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(0 . 66 gm . to natients who wei .~hed less than 50 kg .). The average 
dDse for the ~roup was 0 . 9 gm ~ and three patients received 2.0 
~m . 0 . 33 gm . was given with each meal because the dr~g was given 
to experimental animals that way and because it was less nausea-
ting, than when gi-7 en before or after meals . Some of the sub-
jective symptoms and toxic effects noticed during treatment were: 
(a) feeling of well being following treatment (25 percent); 
(b) dermatitis (1 case) clearing on cessatiDn of treatment; (c) 
initial rise in temperature followed by gradual recession in 
patients with exudative type of lesions; (d) mildly increased 
nulse rate in most Patients ; (e) cyanosis 0f finger tips and lips 
but no dyspnea (50 per cent); (f) mild to severe nausea (25 per 
cent);which gradually improved, and vomiting in a few cases; {g) 
nerv0usness (25 per cent); (h) phot0phobia (27 per cent); (i) 
diplopia (13 per cent); (j) sli~ht tremors (33 per cent) . 
The blood picture was typical. At first an initial drop 
occurred in the hemoglobin (1 . 98 gm . ave .) with gradual return 
to almDst pre-treatment levels. Liver and iron were not given 
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because the authors wished to see the response of the hemopaietic 
system to the dru~ . There was no hemolytic type anemia observable 
following the r eturn to normal nor any indication of serious de-
ran~ement of blood formingpotentialities . The white count remain-
ed essentially un chanP"ed and at no time was there e v idence of se-
vere leukopenia or agranulocytosis . 
Studies on diasone concentration in the various body fluids 
showed effective blood levels were main~ained at 1 . 5 to 2 . 0 m ~m · 
ner 100 ml . blood serum . Other findings were: 
cerebrosninal fluid 1 . 5 to 2 . 0 mgm . per 100 ml . 
urine 44 to 80 
bronchial secretion 0 , 5 to 1 . 0 
(all free diasone) 
Diasone seems to have a lower effective blood level than promin . 
Four findings were used to measure improvement: (1) x-ray 
films ; (2) sputum conversion ; (3) sedimentation rate; (4) tern-
perature . Evaluation of improvement wa s difficult because of 
variable findin~s . 
The followin observations of therapy were m' de . X-ray : 
sliP"ht t o mode~ate resolution was observed in 90 per cent of the 
cases . There was increased fibrosis in about 30 per cent . Forty 
three ~er cent of the cavities we r e no lon~er in evidence . 
Sputum ~ onversion: In 45 to 125 days , 59 per cent of all 
cases became suutum ne~ative . This occurred in 100 per cent of 
the minimal cases , 68 per cent in moderately abvanced cases , 
and 29 per cent in far advanced cases . Six consecutive negative 
24 hour concentrated sputum specimens were used as the criteria 
for sputum c0nversion . 
The temperature and sedimentation rate showed improvement 
in most of the cases . 
The majority of the patients received diasone for five 
and one-half months (164 days) . 
As a result of this study the authors came to the following 
conclusi:ms : 
1) Dia s one shoul d be adrn ini - t ered f oP 120 days for proper 
evaluation . 
2) The observations of 122 to 217 days which is short for 
tuberculosis showed striking results in some cases . 
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3) They felt that the best imnrovement occurred in the first 
60 to 90 days of treatment . 
4) They felt no regrets for using chemotherapy in place of 
bed rest or collanse therapy . 
5) They found no evidence of bronchogenic spread of the 
disease during treatment . 
6) They believed that two patients were alive bedause of 
diasone and six were brought to a condition favorable 
enough to allow thoracoplasty . 
7) They found that two patients with spine lesions responded 
well and two patients with diabetes tolerated the drug 
well . 
8) They felt thet because 0f the unpredictability of tuber-
culosis and inadequate methods of clinical control, these 
results had to be interpreted conservatively and thc.t 
other factors might have been responsible for the effects 
observed . 
In their opinion diasone is not the ideal chemotherapeutic agent 
for the treatment of tuberculosis . 
In a later paper (55) they reported a progression of the 
general beneficial trend that had been noted with the administra-
tion of the dru~ and attributed it to lapse of time, medication 
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or a combination of both . 
In March , 1943 , Pfuetze (56) and his group began the use 
of diasone at Mineral 'S0rings Sanatorium, Illinois and in Septem-
ber , 1944, reported the r esults of a 14 month study on 36 patients 
who had received an average daily dose of 0 . 9 gm . for 120 days or 
longer . The total number of days of trea t ment ranged from 120 
to 399 days . The average daily dose of the patients was 1 . 70 
gm . The group included a renresentative cross-section of patients 
who were not receiving adequate collapse therapy before treatment 
was initiated . Four patients had been classified as minimal, 
15_ as moderately advanced , and 17 as far advanced . The type 
of disease process included exudative, fibroid and caseous lesions . 
Aside from chemotherapy the natients received routine sanatorium 
bed rest and general care . 
The results in this series wer~ distinctly less favorable 
' 
than those obtained by Petter and Prenzlau and fell considerably 
short of the author's hope for a chemotherapeutic adjunct in the 
treatment of human tuberculosis . Only two patients in the series 
showed what might be exnected as marked or unexpected improve-
ment as measured by serial x-ray examination. Eight of the pa-
tients showed definite spread of their disease process while taking 
the drup: . Ten showed moderate improvement , 7 slight improvement 
and in 9 no change could be demonstrated by repeated x-ray 
studies . 
The authors confirmed the findings of Petter and Prenzlau 
that diasone was somewhat less toxic than p~omin in similar 
doses to the hemonoietic system but it, to o , was accomnanied 
by undesirable side reactions . A reduction of hemoglobin occur-
red in 18 per cent of the 36 patients ranging in degree from 
6 to 24 per cent. Nervousness, irritability, and anorexia were 
not uncommon . In all but 3 of 36 natients there was cyanosis 
but the degree of this did not seem to bear any correlation to 
t he intensity of the other side react ions. Some inve s tigators 
(63) have s hown concern regardin~ the possible deleterious effect 
of this ryhenomenon in both guinea pigs and human bein~s who are 
being treated for tuberculosis . 
Diasone is not the innocuous drug which the results of these 
,.. 
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two nreceding studies would indicate it to be . In June , 1944, 
Pfuetze (60) reported a severe reaction in · one of his patients 
after receivins the comnound . Characterized by fev~r up to l04°F~ 
angina , nausea, vomiting, and a generalized na.culo-papular erup-
tion which became vesicular and finall y extensively exfoliative . 
This patient , however , had had an eruption two years previously 
when receiving sulfonamides for an influenzal infection and the 
author thought that this reaction might represent another manifes-
tation of sulfonamide sensitivity which was induced by a compound 
chemically related to the sulfona~ides . 
Robitzek (61) reported a fatal oemphigoid reaction in an 
individual receivinp diasone that was characte riz ed by lesions 
in the skin and exfoliative les ions in thetrachea with death from 
asph~xia and broncho-pneumonia. 
Benson and Goodman (62) evaluating the use of the drug on 
i 
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22 patients with all degrees of nulm~nary involvement reported 
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that only 4 natients might possibly have benefited from the drug 
which was administered for 120 to 160 days . They concluded that 
it was too toxic for general use and had to b e given under strict 
supervisi~n. Toxic and untoward responses renorted in their 
series were cyanosis, anemia , exfoliative dermatitis (in 2 cases, 
requirin~ withdrawal of the drug) , fever, jaundice, tremors, 
diplo oia , and enlargement of the thyroid . Their estimate as to 
the drug ' s ultimate usefulness was rather ~uarded and cautious . 
The severest critics of the use of diasone in tuberculosis 
have been Corper and Cohn (63) who have renorted from their ex-
neriments that di csone shows n~ bacteriJcidal or bacteriostatic 
activity in vivo or in vitro in the concentrations attained in 
the body . The me chanism of action ~as thought to be a result of 
the inhibitory effect on the tubercle bacilli of anoxemia of the 
host's internal environm ent produced by de struct ion of red cells . 
They felt that patients receivin~ 1 gm . of diasone a day did not 
show an anoxemia sufficient to produce what they c onsidered an 
inhibitory environment for the organism and, ther efore, it had 
been of no use in the treatment of tuberculosis. Since they 
thoup:ht the drug was so toxic they recommended that further in-
vestigations be limited to animal exnerimentation. 
Whet her or not this explanation may be valid, it can be con-
cluded fr~m the results of clinical studies that diasone falls 
distinctly short of the ideal chemotherapeutic agent for the 
treatmen+ of tuberculosis . 
Pre>mizole 
Tpe mo ~ t recent sulfone drus that has been- under investiga-
tion is 4, 2 diamino p~enyl 5' thiazole sulfone, known as 
"promizole ." This compound is structurally different than the 
other sulfone c:• studied and may _represent the beginnint: of a 
new serie s 0f comnounds that have the potentiality of inhibiting 
tuberculous infection. 
.s - c. - j'\1 If ... 
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This dru~ is an is0mer of· sulfathiazole. The re-arrangement of 
the molecule Profoundl:r affects the chemical, >Jharma_colo~ical 
and therapeutic Properties of the substance and ev ne ·.,ce from 
human trials (17) show that the metabolism, con jur ation ana 
excretion of the drug are distinctly dissimilar. 
Promizole is soluble in water at pH 6.5, at temperature 
280 to· 30° C. to the extent of 30 to 40 mgm . per 100 ml. It is 
readily soluble in dilute acids, acetone, diaxone, dilu~e 
(70 pe~ cent) alc~hol. It is moderately se>luble in et~anol, 
ethyl a~etate and ether. It has a me>lecular weight of 255 · 
Hinshaw. Feldman, and -lann (64, 65) performed the animal 
experiments on the drua. The oru~ is well tolerated by guinea 
pigs and in d0ses of 200 te> 225 m~m . per day, one-half of the 
dosage emPloyed with promin, produc es comparable therapeutic 
effects. It causes a mueh less severe blood dyscrasia which is 
e asily reversible and the spleens of the animals upon conclusion 
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of the experiments were not dark and hypertrophied as was noticed 
f~llowing the us e of prJmin and diasone. A comnarison of its 
activity with DPS (64) yielded the followin,: averagesindices of 
infection : c ontrols , 66 . 4; DPS , 4 .4; promizole, 6 . 2 . The results 
of another exneriment (65) were as follows : 
Gr up Animals Tre ated Post Infection Tuberculous index 
I 20 not treated 83 
II 20 promin 6 weeks 10 .8 
III 20 promizole 6 weeks 16 . 4 
IV 13 promizole 10 weeks 25 
v 15 promizole 14 week s 33 ·8 
The blood levels were 1 . 5 to 4 . 2 mgm . per 100 ml . (ave . 2 . 6) . 
The effects of nromizole were slightly less than those of 
promin even thou ezh it was used in one-half the dose of the latter . 
It is significant to note that some inhibition of the disease 
pr8cess occurred when the treatment was started 14 weeks post in-
fection . Promizole exerts a baceriostatic rather than a bacte-
riocidal effect since virulent organisms were s·iolated from the 
animals at t he ind of infection; however, in 4 of the 14 s pleens 
examined no tubercle bacilli were cultured. Promiz ole was found 
cons i s tently less effective in ~reventing tracheo-bronchi a l lymph 
lesions whereas promin s howed a greater therapeutic effect at 
this site . 
Another feature tha t has been observed in t he experimental 
use of the drug is enlar~ement of the thyroid (65, 66) . There 
is hypertrophy and hyperplasia of the acinar cells with increase 
in the size of the gland, and associated cytologi c c hanges are 
nated in the pituitary which may have some relationship to the 
chan~es seen in the thyroid . The increase in size is reversible 
and the ~land returns to normal u~on cessation of therauy. 
Pinshaw , Feldman , and fuetze (67, 68~ have started the 
administra:'· ion of the dru~Z in nat ients with pulmonary and extra-
pulmonary tuberculosis . In a nreliminary report (67) they dis-
cussed modes of adm 1nistration , dosage, taxicity but felt at 
that time that results were not definite enough to warrant any 
conclUBion regarding the efficacy of the drug~ They thought 
that promizole fell distinctl y short of the ideal chemothera-
peuti c remedy . Large doses (12 to 16 gms . per day) produced 
moderate to severe anorexia in 3 to 4 weeks . This toxic symtom 
could be relieved by ;ziving 8 to 10 ,c;rm . uer day and by supule-
menting the diet with yeast and liver extract. In this dosage the 
blood levels were low , 1.5 to 4 .2 m~Zrn . per 100 ml . (2 . 6 mgm . ave .) 
but were comuarable to those attained in successfully treated 
gui.nee pia·s . Concentrations were hi~her with massive doses and 
in natients with renal dama~e . No adverse effects on the blood 
were noted unless massive doses of 24 g~ . were ~iven . 
Promizole was found to apuear in he urine in large amounts 
indicating that more than 30 per cent of the drug ingested was 
excreted . The cancentration of the drug in the urine has been 
noted up to and greate r than 1 per cent . This is greatly in 
excess of its solubility but the investi kato rs have shown that 
the druq is chan~ed within th e body to a hygroscopic conjugation 
product which is readily s:Jluble in all oroportions in water . 
It is, therefore , apparent that the drug will not cause renal 
damage by concretions. The urine of patients tak1ng promizole 
in large quantities fre::J_uently bec0mes pink due to an unidentified 
dye product of the metabolism of oromiz:Jle . 
Pfuetze (56,68) reported un favorabl e results with promizole 
in the treatment of 5 case s :Jf tuberculous meningitis and 2 
cases of miliary tuberculosis . 
Keith (69) has reported an anparent cure of tuberculous 
meningitis in an infant within 6 days by the use :Jf up to 3 . 2 
grams of promizole a day . This report has to be taken with some 
reservation since few acid fast organisms were demonstrated on 
a smear of the spinal fluid by the auramine method, and none were 
found when the Ziehl-Nielsen method was employed . Guinea pig 
inoculation was ne8~tive after 8 weeks . 
In a later renort (63 ) Hinshaw, Pfuetze and Feldman des-
cribed the tre atment of 10 patients with r enal tuberculosis in 
wh0m there was some symDtomatic r lief but in whom tubercle 
bacilli could still be isolated after 10 months of treatment. 
They continued the treatment because of the palliative effect and 
hone that cumul~tive benefits mi~t result . 
A controlled study of nromizale in uulmonary tuberculosis 
therapy ws s still in pragress but definite re sult s were not avail-
able at the time . 
The y believed that more encouraging results had been obtained 
in the treatment 0f other forms of extrapulmonary tuberculosis 
(c~taneous tuberculosis and tuberlid, tuberculous lymphadenitis, 
tuberculous sinuses, etc . ) but did not feel conclusions were as 
yet warranted . 
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In no cas e were toxic manifestations of critic al severity 
noticed in more than 85 patients of whom 75 per cent had been 
treated fo r prolonged periods (30 to 300 days) . There have been 
.no instances of thyroid hyperplasia or changes in thyroid function 
even thou~h patients had received large amounts of the drug 
for a considerable length of time . 
Although detailed clinical studies on the use of promizole 
are not comple t e, it seems probable that it is not the answer 
in the search for the ideal chemotherapeuti~ agent in the 
trea.tment 'of tuberculosis for reasons not well understood. ( 68) 
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Other Sulfones and Sulfonamides 
During the course of research in the chemotherapy of 
tuberculosis many sulfonea and sulfonamides have been investiga-
ted (26 , 70- 75) . Smith , Rosenthal, and Jackson (70) have re-
norted on a n-pl~sJhoryl derivative of DPS which appears to have 
a marked inhibito r y effect on experimental tuberculosis in guinea 
pias . Feldman and Hinshaw (74) found another sulfone, 4 amino-4 
propyl amino diphenyl sulfone , to h8ve therapeutic properties 
and low toxicity comnarable to nromizole experimentally . Four 
patients were treated with this compound in doses up to 3 . 0 gm . 
per day with no apparent effect . The drug could not be detected 
in the bloodstream . Gubner (73) has described the prolonged ad-
ministration of n4-caproyl-nl-hydroxysulfonilamide ("sulfabena-
mide") , a non-toxic fatty acid sulfonamide in cases wi th pul-
monary tuberculosi s . He administered the drug in quantities up 
to 16 ~m . per day for an average neriod of 10 months to 5 patients 
with advanced bilateral nulmonary tuberculosis , He described 
snutum reversal in all natients , an average gain in weight of 
33 pounds and moderate resolution of pulmonary infiltration as 
seen by x-rays . No conclusions, however, were warranted. A 
more recent animal exneriment by Smith and McClosky (75) showed 
sulfabenamide to be more toxic for guinea pigs than the sulfones 
and other sulfonamides studied . 
None of the above dru. s have shown any advantage over the 
few dru s alreacy i n use and extensive clinical trials would be 
superfluous . 
The c0mparative efficacy of some sulfones and sulfonamides 
in exDerimental tuberculosis is summarized in Table I . 
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TABLJ~~ I* 
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Streptomycin and Other Antibiotics 
Because of the toxic reactions end the questionable results 
that attend the use of the sul fones, attention has tu'rned to 
the antibiotics as oossible bacteriostatic agents apainst the 
tubercle bacillus . Penicillin is without effect in tuberculosis 
but has been found to be ~f some value in the treatment of pyo-
aenic emuyema complicatin~ nulmonary tuberculosis or therapeutic 
oneumothorax (76-7S) . A new antibiotic, streotomycin, isolated 
by Waksman and his group (79, 80) at the ~ew Jersey 5tate Agri-
cultural Station from f:Q_tinomyces g£!_seus has been found to have 
an effective bacteriostatic acti~n a~ainst a wide r~nge of flora 
includin~ m. tuberculosis (81) . Streptomycin (80) is similar to 
the substance strentothricin isolated earlier by Waksman from 
Actinomyces lavendulae in having similar biological, chemical 
and nhysical properties, and a similar bacteriostatic spectrum . 
Both substances act on vc,rious p;ram positive and gram ner:ative 
organisms; they differ , however, in the fact that strentomycin 
is more active against certain bacteria in each group, i . e., 
Bacillus mycoides and m. tuberculosis in the former, and proteus 
vulg2ris and oseudomonos aerugenosa in the latter. Both are 
characterized by low toxicity in the experimental animals and 
by high activity against ~ram positive and gram negative organ-
isms . Streotothricin is comparatively ineffective in combatting 
experimental tuberculosis in guinea oigs. (82) 
Hinshaw and Feldman (83, 84) conducted the animal exoeriments 
and found streptomycin to control exoerimental tuberculosis 
successfully in the guinea pig . In a series of 3 experiments 
comparable in technique to thos e employed in testing promin , 
streptomycin g ave more effective results. At the end of 215 
days the average index of infections in the controls was 80 . 4 
and that in the animals treated with streptomycin was 1 . 24 . 
Necropsy studies showed that the liver of animals who had pro -
gressive destructive lesions at biopsy had either no evidence 
of tuberculosis involvement or small, inactive foci . A dosag e 
of 6000 units per day was ~iven in f ou r divided doses subcutane-
ously into the axilla. The streptomycin nreparatioreused had a 
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low toxicity for guinea pigs and were tolerated without deleterious 
effects for prolonged periods of time . In most cases strepto-
mycin exerted a suppressive rather thati a bacteriocidal action 
a gainst the tubercle bacilli but in 8 out of 23 spl eens tested 
by cul t ure and animal inoculation, no organism could be isolated . 
Under favorable circumsta ·-~ ces, therefore , streptomycin may have 
sterilized the tuberculous infection in guinea pigs completely . 
In some inst a r., ces ( approximately 39 ner cen t) sue ces sful treatment 
with streptomycin resulted in reversal of a positive t o a ne ~ative 
sensitivity to tuberculin . The authors felt that larger doses might 
have enhanced the bacteriostatic effects of the drug . 
Hinshaw and Feldman (85) have used streptomycin in clinical 
tuberculosis since December, 1944, in 34 patients . They are re-
ceivin rr minimal therapeutic doses of 800,000 to 1,200,000 S units 
per day in divided doses of 100,000 to 150,000 units intramuscular-
ly every three hours (86) . In the ir patients this unitage maintains 
a blood level of not less than 5 to 10.0 S units per ml . of 
serum . The intra,muscular method of administration was used 
and no toxicity was noted except local pain at the site of 
administration. Rare reactions of increased t emperature, malaise, 
or arthralgia were noted durin~ the course of trea t ment which. 
became less frequent as more nurified preparations of the drug 
became available for use. Four cases of sensitivity developed 
but the oatients were desensitized by small gradually increasing 
amounts of streptomycin. One case of transient deafness and 3 
cases of apparent disturbance of function of the vestibular appa-
ratus was observed followin 13 urolon~ed administration of lerge 
doses of the drug which the authors b e lieved might possibly be 
due to a selective neurotoxic effect on the eighth cranial 
nerve. 
The streptomycin did not seem , to have any rapid curative 
action on the natients . Sixteen oatients were treated fo~ l to 
3 month s, and .g were observed 4 months after therapy. The drug 
seemed to exert the most favorable effect in extensive and pro-
gressive lestons of kno"'n recent ori.c:<;in which tended to heal 
oromptly in a manner resembli:rgthe netural process of healing . 
Widely dlstributed lesions of hemato~Zenous spread seemed to bene-
fit frJm the drug in some but chanoes were not apoarent for 3 
to 6 weeks. The results in 4 uatients with tuberculous empyema 
were di sapp ointing; however , improvement was noted in :fom:·-f'if'ths 
of the patients with renal tuberculosis in whom the bacilli dis-
appeared from the urine 2 to 4 weeks following the onset of the 
treatment. There was ver. ' prompt and striking respons e to 
therapy in two - thirds of the Dat ients suffering from draining 
sinuses as the result of tuberculous lymph~denitis. 
The authors copcluded that streptomycin has a limited 
suppressive effect with no evidence of rapid bacteriocidal 
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action in the tuberculous patients' studied . They felt that strep-
tomycin was of s~me benefit in the m~r~ unusual cases of pul-
monary and extrapulmonary tuberculosis and that it was of limi-
ted effectiveness in chronic fibr~-c aseous lesions . More ex-
tensive , controlled clinical trials are required before the 
r-:1le of streptomycin can be determined in the treatment of 
tuberculosis and these will probc;bly soon be under way when 
purified streDtomvc in becomes available in large quantities . 
At present streptomycin does not represent a cure for tubercu-
losis . 
Recent studies (87, 88) of the absorption, distribution , 
excretion, and toxicity of streptomycin in man h ave shown that 
intravenous an"l intramuscular injection of streptomycin are 
ranidly excreted in the urine but not as quickly as penicillin . 
Considerable amounts are de t ectable in serum at the end of 6 hours 
followinrr the administration of a sin~le dose, therefore, effec-
tive blood levels of the dru~ can be maintained by administering 
it at intervals of 6 to ~ hours . The drug is not absorbed from 
the rrastrointestinal tract but this is not due to ina ctivation by 
gastric secretions. The drug is distributed th oughout the body 
fluids followin<Z Darenteral injection and tra ces appear in the 
cerebro-spinal flu d . The· dru shows l~mited toxicity for man 
and oroduces no renal or hemopoietic damage so that as far as 
t0xicity is concerned this would be a suitable a~eft for adminis-
tration in tuberculosis . 
Reoorts have been .made of other ant~biotics (89-91) which ' 
demonstrate a bacteriostatic effect in vitro against m. tuber-
culosis but which have not yet been used in .in ~1v6 exneriments . 
Asheshov an~ Strelitz (g9) have renorted the isolat ion of a 
substance from Asnerg_i1'lus fumi~tus which inhibits the tubercle 
bacillus in 1 : 1 , 400 , 00 ~ dilution and often kills the organism in 
- 1 : 500 , 000 dilution . Kur ~ng (90) has reported that an extract 
of Asoe£gillus ust~~ inhibits a strain of tubercle b&cillus in 
1:200,000 t ·o 1:400,000 dilution . Gerber and }ro JS (91) have 
isolated a oroduct from an as yet incompletely identified mold 
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of the Aspergillocae group which also demonstrates ~bme bacterio-
static effect on the organism . 
Ac'.dendum; 
: n the series o p .= tients treated by Hinshaw and Feld ·nan ', ith 
strertom~'cin, two-thirds of the cases of miliary tuberculosis 
showed some improvement during the course of treatment. 
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Combined Treatment with Promin and.Streptomycin 
The most encouraging · work performed in the treatment of' 
exuerimental tuberculosis with chemotherapeutic agents has been 
that of Smith and ;,.kClosky (92) who combined the use of promin 
and strept0mycin . The authors felt that not only was the com-
b4.ned treatment better than either agent alone but that it repre-
. ' "- ~ 
sented the best results obtained in the treatment of experimental 
tuberculo s is . The " treated a (l'roup of guinea Di O' s for 90 days 
with 5000 units of streptomycin which is one-twent h ieth of its 
tolerated dose and another grouu wit h 0 . 5 gm . promin per kg. body 
weight which is one half the maximum tolerated dose for guinea 
pi br s . Comparable results were obtained indicating that in this 
exneriment streptomycin had a chemotherap eutic index ten times 
greater than that of promin . Under the conditions of the experi-
ment , little more could have been expected from promin while the 
efficacy of larger doses of streptomycin are conjectural . Using 
the two agents together , the results indicated a synergistic rather 
than an additive effect . Expectin~ a chemothera~eutic efficacy 
equal to the results of the two agents combined, t h e actual index 
was three times what was exuected from simple summation. Five 
per cent of the promin group, 15 Per cent of the streutomycin 
group and 65 per cent of the combined group showed no evidence of 
macroscouic tuberculosis . In the latter group the other 35 per 
cent showed no evidence of macroscopic tub erculosis and the lesions 
consisted mainl .r of small localized tuberculous a bscesses in 
the small intestine or miliary nodules . 
The authors felt that these findin g s warrant t ile cautious 
application of combined trea" ment in suitable clinical cases 
while search for more eff ective sulfones and for better methods 
of streptomycin administrati0n continues . 
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Chemotheraneutic Testing and Evaluation 
The problem of chemotherapy in tuberculosis has been 
pursued with renewed vig::>r since the discovery of the agents 
which have been shown to exert some bacteriostatic effect against 
the tubercle bacillus; however, the nature of the tuberculous 
Process, bot h ex~erimental and clinical, is such that definite 
and conclusive results cannot be obtained in a short period of 
t~me with chemotherapeutic aaents . The development of tubercu-
losis in guinea pi~s is relatively slow, and a sine:le experiment 
mR" take up to a year or more t:; nerform . The experience of 
v crious inve sti~ators in the past five years of chemotherapeutic 
testing has prompted them to a+tempt a standardization of pro-
cedures and uniformity in greding results so that a more ranid 
and accurat e evaluation can be made of the newer agents that 
are constantly being discovered . Research in chemo therapy has 
bec,me one of the most active field of investigation in tubercu-
losis and is bein~ actively undertaken by many groups . 
Hinshaw and Feldman (93) hc>ve de s cribed practical methods 
for the auick evaluation of chem:;therapeutic agents in experi-
mental animals as rapidly as possible with the facilities that are 
at hand . They feel that in vitro experiments are less reliable 
tha~ in vivo tests (f ,r reasons given in a rreviou s section, 
seep . 19 ), and t Lat tle metnods su ?~ested are based on the 
premise thbt c~emotheraneutic att&ck should be directed against 
tubercu losis as a disease rathe r than against the organism alone. 
They sug~est a preliminary screening te s t of 60 days to determine 
the effic a cy of the agent tested . If favorable results are 
obtained, than a more extensive cont rolled experiment is per-
forme d where treatment is instituted 6 weeks followin~ inocu-
lation with the organism . They have ~iven special c onsi~ eration 
t0 the care and s electi ·:m of animals, the infective inoculum, 
administ rati0n of t he test substance and recording of the 
results so that on a basis 0f well c ont rolled exueriments de-
finite c onclusions can be reac!·~ed t hat would indicate wl1etner 
clinical trial of t h e material is warranted . On the ba sis o f 
5 years ' exueri snce, they con s idered t hei r methods. to be 
reliable and c apable 0f giviniS results tha t c ould be duplicated 
else·where . 
Their criteria for satisfactory agents in combatting 
exner imentall y induced tub erculosis in gu inea piV:s are : 
l) The a g ent should be well tolerat ed and not p roduce 
serious or irrev ersible physiological damag e . 
2) The substance should reverse a well-established 
tuberculous infection'from a strain of known virulence 
fr0m a de s tructive nr0 a:ressive urocess to one that is non-
pro~ressive and will eventually re solve, fibrose, or 
c o lcify and he nce ~roduce extended longevity of t h e animal . 
3) The substDnce should eliminate or render avirulent 
bacilli from t he or~"'ans of .., redi lect lon sucr_ as the l i ver , 
spleen , or lun~s, and he n ce nreclude reactivation of the 
infection from t hese sites . Thi s criterion h&s n ot be en 
c ompletely f ulfilled so f a r by any of the agents te s ted . 
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Streptomycin has shown a ~reater tendency toward fulfilling 
this requir-ment tLan the other drugs but not to a sufficient 
degree to enable it to be deemed the ideal Cilemotnerapeutic 
for exuerimental tuberculosis . 
4) The desired results should be obtained within a 
reasonable length of time. Taking into account the slow 
healin~ of tuberculous lesions, six months is felt to be 
a reasonable time for this effect to become apparent . 
Exnerimental tuberculosis in ~uinea ni..:s is a different 
disease tha r clinical tu~erculosis in the human and it has been 
apnarent tbat fav;rable results in the animals cannot be readily 
translated to human disease . The natholo~y of human tuberculosis 
(fibrosis, caseation, cavitation) nrcbably erects a mecnanical 
barrier that may prevent the access of any agent in sufficiently 
ler~e quantities to the lesions in order to exert a bacteriostat ic 
effect. 
Hinshaw and Feldman (94) felt that t h e final acceptance or 
rejection of chemotberaneutic drugs in tuberculosis must depend 
on exnerimental and clinical studies which have been ri~idly con-
trolled and accurately recorded . They have recommended the 
followin::r procedure for the evaluati::m of the dru~:r clinically: 
1) ~he chemicel ~tudies must be nreceded by extensive 
animal ex~er!ments 1n which demonstrable reversal of the 
disease has occurred . 
2) Prel i minar:r eyt') 3ri:nents should indicate possible 
toxic side reectionsmd tte means for treatin~ or preventing 
their apnearance. 
3) The candidates for study sho~ld be · carefully selec-
ted with diseases that are as similar as pos s ible rege.rding 
type and pro~nosis ~f the lesion . The group should be 
evenly divided; one-half should r ceive ihe drug and the 
other should not . 
4) The number of patients should be of sufficient 
quantity because of the variable nature of the dise"se . 
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5) Emphasis should be nlaced on the study of tubercu-
lous lesions af recent ori~in which are treated before des-
tructive cran~es have occurred; in these cases the type of 
lesion is more important tha~ the extent of the disease. In 
all the ceses, the bacteriolo~ical proof of the disease 
must be established . 
6) The drug shcmld be given to the limit of the patient ' s 
tolerance before it is abandoned as ineffective . The route 
af administration should be similar to that employed in 
animal exueriments and as far as uossible clinical condi-
tions should anuroach that of the animal exneriment . 
7) The response ta therapy sh~uld be sufficiently 
nr~mpt (2 to 4 months) and the course of the d~sease suffi-
ciently unlike that qf the control series to make results 
definite. It is sugqested that the data be reviewed by 
radialo~ists and clinica+ consultants who are n~t familar 
with the treatment bein~ recieved b y the patient . 
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These princinles are generally adhered to by most men 
warkin-rr in the field. There is a tendency amoniZ' certain workers 
and reviewers of medical literature with a less scientific 
anpr:::>ach ta the problem to ascribe greater therapeutic properties 
to drugs than is justifiable an the basis of objectively obs er-
ved results; this has aften resulted in premature publicity in 
s0me journals and the lay nress about dru g s that are under an 
exnerimental investi~ation. Diasane was one agent that received 
this nublicity and final clinical results certainly did not 
indicate that it was the ideal chemotherapeutic agent for tuber-
culosi s . Reports of new miraculous cures are bad not only for 
the morale :::>f the tuberculaus natients but may also induce certain 
sufferers from the disease to relinquish standardized methods of 
treatment for chem0therany in the hope for a quick cure. At this 
stage of our nresent kn:::>wlediZ'e of the subject this would be 
most unfortunate. 
Pinner (95) comment~_n~ on the evaluation of chemotherapeutic 
agents has reemphasized the need for greater accuracy in report-
iniZ' observed results and renorting all and not just a portion 
of the natients treated. Subjective feelings of well being are 
of little m0ment , and observec effects should be reported in 
terms of resorntion, fibrosis, and sputum reversal (with full 
statements as to the methods employed in examination~ . He differs 
from most investigators in feeling that animal experiments are 
costly and time consuming and thinks that they should be dis-
nensed with . He favors the use of nromis ing drugs from in 
vitro exneriments on natients with early lesions for a brief 
time and more extensive studies if these results are favorable . 
He also is e>f the opinion that true clinical controls in tuber-
cule>sis are unattainable because of the variable, unpredictable 
nature of the disease and because of difference in hereditary 
and constitutional factors in the individual patient . 
The nee~ for careful, intelli~ent r~search in this field 
is paramount . It seems apparent from the criteria of the 
evaluat ion of chemotherapeutic a~ents that complete cures are 
not expected at present in all case s even with the most 
effective druCJs . 
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Conclusions 
Fr')m the f0reg')int:'" discu s sion of some of the v:ork that has 
be <:> n &eoin:- on, one ma;r c me to the conclusion that no "cure" f) r 
tuberculosis hes been found in the c he otheraneutic drugs that 
have been recently studied . Analysis of clinical re sults indica-
tes that the efficacy of chemotheraoy to date has been some-
what qu e s ttonable in nulmonar:r tu.bercu.losis since the most favor-
able effects of the dru~s were seen in those lesions which tend 
to heal under the older , standard form of treatment . Lar~e con-
trolled studies were not n~rformed, so that it cannot be defin-
itel~ said whether the dru~s were actually of benefit in the 
' disease . How ever , the striking results obtained exnerirnentally 
with the ce agents cannot be i rnored since they renresent tLe 
best effects that have ever been achieved . The intensity of the 
research nerhans is an augury for the importance ana nromise 
that chem0therany may hold for the trea tment of certain tubercu-
lous in.ections , esnecially the early exudative nu lmonary lesions . 
It might be unfair to judge the merits of chemotherapy in tuber-
culosis on the strength of unsuccessful results in the treatment 
of chronic , fibrotic , or caseous nulmonary lesions just as it 
would be unfair to judge the efficacy of the sulfonamides or 
nenicillin the the treatment of conditions such as chronic lung 
abscess . 
On the basis of present s udie ' , promin and diasone certainly 
do not fulfill the criteria that have been establish ed for the 
ideal c~e~otherapeutic a ·ent in tuberculosis . The status of 
' 
promizole, strentomycin, or some comb~ned treatment method has ~ 
yet to be es tablished clinically , and investigations are being 
carried out at present with this end in mind . Though these 
dru~s may not prove to be effective, it is gene~all y felt b y 
men working in this field that they are on the right track to 
the discovery of compounds of a similar chemical nature which 
may be of value in treating the disea se . 
Because of the pathogenesis and urotean nature of' tubercu-
losis, especially of the pulmonary variety, chemotherapy may be 
relegated to use only in certain selected pati ents with early 
lesions, in some forms of extrauulmonary tuberculosis, or in 
ureparin~ uatients for various sur~i cal u rocedures . 
Neither undue ontimism nor frank pessimism is warranted 
concerning the uossible role of' chemotherapy in tuberculosis . 
Although it will probably not become a cure ~ se, · it m;.' y be 
added as a valuable tool to the armament~rium of oht h isio • 
t herapists . 
61 . 
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